SCHEMBL2014549

SCHEMBL2014549

COc1cc(C(=O)N(C)C(CCNC(=O)c2nc3ccccc3n2C)Cc2ccccc2)cc(C)n1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HCRTR1 O43613 2/20 0.45
▸ HCRTR2 O43614 2/20 0.45
▸ OPRM1 P35372 1/20 0.37
▸ OPRK1 P41145 1/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ MAPT P10636 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ LMNA P02545 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ RECQL P46063 1/20 0.35
▸ KLK5 Q9Y337 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ HTR1A P08908 1/20 0.34
▸ ASAH1 Q13510 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13138972 0.87 HCRTR1 (0.50) HCRTR1HCRTR2SMN1; SMN2MAPTNPC1
SCHEMBL13139051 0.86 HCRTR1 (0.47) HCRTR1HCRTR2SMN1; SMN2MAPTNPC1
SCHEMBL13139031 0.86 HCRTR1 (0.57) HCRTR1HCRTR2SMN1; SMN2MAPTNPC1
SCHEMBL13139038 0.86 HCRTR1 (0.48) HCRTR1HCRTR2SMN1; SMN2MAPTNPC1
SCHEMBL13138975 0.84 HCRTR1 (0.50) HCRTR1HCRTR2OPRM1SMN1; SMN2MAPT
SCHEMBL2054319 0.83 HCRTR1 (0.64) HCRTR1HCRTR2OPRM1OPRK1NPC1
SCHEMBL2016237 0.83 HCRTR1 (0.64) HCRTR1HCRTR2OPRM1OPRK1NPC1
SCHEMBL13138945 0.83 HCRTR1 (0.45) HCRTR1HCRTR2OPRK1SMN1; SMN2MAPT
SCHEMBL13139073 0.82 HCRTR1 (0.53) HCRTR1HCRTR2SMN1; SMN2MAPTNPC1
SCHEMBL2013880 0.82 HCRTR1 (0.46) HCRTR1HCRTR2OPRM1OPRK1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 — — WO disclosed
Send feedback